Crestline Management LP bought a new stake in HCP, Inc. (NYSE:HCP) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 132,209 shares of the real estate investment trust’s stock, valued at approximately $3,693,000. HCP accounts for approximately 0.6% of Crestline Management LP’s portfolio, making the stock its 20th biggest holding.
Other institutional investors have also added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. boosted its holdings in HCP by 2.1% in the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 89,768 shares of the real estate investment trust’s stock valued at $2,363,000 after purchasing an additional 1,883 shares during the period. WINTON GROUP Ltd bought a new position in HCP in the 3rd quarter valued at $282,000. Commonwealth Equity Services LLC boosted its holdings in HCP by 1.1% in the 3rd quarter. Commonwealth Equity Services LLC now owns 318,337 shares of the real estate investment trust’s stock valued at $8,378,000 after purchasing an additional 3,370 shares during the period. Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in HCP by 2.4% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,850,958 shares of the real estate investment trust’s stock valued at $48,717,000 after purchasing an additional 44,208 shares during the period. Finally, Toronto Dominion Bank boosted its holdings in HCP by 1.1% in the 3rd quarter. Toronto Dominion Bank now owns 305,363 shares of the real estate investment trust’s stock valued at $8,035,000 after purchasing an additional 3,390 shares during the period. 94.74% of the stock is owned by institutional investors.
NYSE HCP opened at $31.13 on Friday. HCP, Inc. has a 52-week low of $21.80 and a 52-week high of $31.88. The company has a quick ratio of 0.64, a current ratio of 0.64 and a debt-to-equity ratio of 0.85. The firm has a market cap of $14.87 billion, a PE ratio of 17.10, a P/E/G ratio of 7.75 and a beta of 0.46.
HCP (NYSE:HCP) last posted its quarterly earnings data on Wednesday, February 13th. The real estate investment trust reported $1.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $1.30. HCP had a net margin of 57.41% and a return on equity of 18.40%. The company had revenue of $441.92 million during the quarter, compared to the consensus estimate of $445.81 million. During the same period in the previous year, the firm posted $0.48 EPS. The firm’s revenue was down .3% compared to the same quarter last year. On average, equities analysts expect that HCP, Inc. will post 1.74 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 28th. Stockholders of record on Tuesday, February 19th were issued a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 4.75%. The ex-dividend date of this dividend was Friday, February 15th. HCP’s dividend payout ratio is currently 81.32%.
Several research analysts have commented on HCP shares. TheStreet raised shares of HCP from a “c” rating to a “b-” rating in a report on Wednesday, February 13th. BMO Capital Markets reissued a “buy” rating and issued a $33.00 price target on shares of HCP in a report on Wednesday, February 13th. Zacks Investment Research raised shares of HCP from a “sell” rating to a “hold” rating in a report on Thursday. Robert W. Baird raised shares of HCP from a “neutral” rating to an “outperform” rating in a report on Monday, January 7th. Finally, Scotiabank started coverage on shares of HCP in a report on Monday, December 10th. They issued an “outperform” rating and a $32.00 price target for the company. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $28.14.
TRADEMARK VIOLATION NOTICE: “132,209 Shares in HCP, Inc. (HCP) Purchased by Crestline Management LP” was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2019/03/17/132209-shares-in-hcp-inc-hcp-purchased-by-crestline-management-lp.html.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Further Reading: Return on Equity (ROE)
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.